Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TDP2 | O95551 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 2/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | CDC25B | P30305 | 3/20 | 0.39 |
| ▸ | S100A4 | P26447 | 3/20 | 0.39 |
| ▸ | PTPRC | P08575 | 2/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4361367 | 0.82 | HRH1 (0.47) | KMT2ATDP2NSD2PAX8ABL1 | |
| SCHEMBL29360004 | 0.81 | METAP2 (0.46) | CES1METAP2PTPRCCTSLCTSS | |
| SCHEMBL27174135 | 0.81 | METAP2 (0.46) | CES1METAP2PTPRCCTSLCTSS | |
| SCHEMBL51294 | 0.81 | METAP2 (0.46) | CES1METAP2PTPRCCTSLCTSS | |
| SCHEMBL30011414 | 0.81 | METAP2 (0.46) | CES1METAP2PTPRCCTSLCTSS | |
| SCHEMBL30322896 | 0.81 | MEN1 (0.47) | KMT2ATDP2NSD2PAX8ABL1 | |
| SCHEMBL13171944 | 0.81 | TDP1 (0.35) | KMT2ATDP2NSD2PAX8ABL1 | |
| SCHEMBL17264311 | 0.81 | KMT2A (0.45) | KMT2ATDP2NSD2PAX8ABL1 | |
| SCHEMBL69894 | 0.81 | MEN1 (0.47) | KMT2ATDP2NSD2PAX8ABL1 | |
| SCHEMBL30724388 | 0.77 | CHRM2 (0.41) | KMT2ATDP2NSD2PAX8ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180226580-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-08-09 | — | — | US | disclosed |
| US-20180145264-A1 | Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device | UDC IRELAND LTD (IE) | 2018-05-24 | — | — | US | disclosed |
| US-20180138413-A1 | DENDRIMER COMPOUND AND ORGANIC LUMINESCENT DEVICE EMPLOYING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-17 | — | — | US | disclosed |
| US-9966532-B2 | Dendrimer compound and organic luminescent device employing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-08 | — | — | US | disclosed |
| US-9850253-B2 | Condensed cyclic compound and organic light emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-12-26 | — | — | US | disclosed |
| US-20150333271-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-11-19 | — | — | US | disclosed |
| US-20140231775-A1 | DENDRIMER COMPOUND AND ORGANIC LUMINESCENT DEVICE EMPLOYING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-21 | — | — | US | disclosed |
| US-8728631-B2 | Dendrimer compound and organic luminescent device employing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20110260138-A1 | BICARBZOLE CONTAINING COMPOUNDS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| US-20070154732-A1 | Dendrimer compound and organic luminescent device employing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-07-05 | — | — | US | disclosed |
| US-5434264-A | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-07-18 | — | — | US | disclosed |
| WO-1995012583-A1 | NEW QUINAZOLINES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE | MERCK & CO., INC. (US) | 1995-05-11 | — | — | WO | disclosed |
| US-5300642-A | α, α-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-04-05 | — | — | US | disclosed |
| EP-0311010-B1 | Alpha,Alpha-disubstituted aromatics and heteroaromatics as cognition enhancers | DU PONT MERCK PHARMA (US) | 1994-02-02 | — | — | EP | disclosed |
| EP-0532054-A1 | Process for preparing alpha,alpha-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5173489-A | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DUPONT MERCK PHARMACEUTICAL CO. (US) | 1992-12-22 | — | — | US | disclosed |
| EP-0311010-A2 | Alpha,Alpha-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1989-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150333271-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, CCNA1 | KMT2A 2285/4885TDP2 3162/4885NSD2 728/4885 |
| US-20180145264-A1 | Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device | SLC43A1, SLC6A19, AOC3 | KMT2A 2040/4885TDP2 3492/4885NSD2 2747/4885 |
| US-20180138413-A1 | DENDRIMER COMPOUND AND ORGANIC LUMINESCENT DEVICE EMPLOYING THE SAME | DCUN1D4, DCUN1D1, FLOT1 | KMT2A 3776/4885TDP2 1299/4885NSD2 4504/4885 |
| US-20110260138-A1 | BICARBZOLE CONTAINING COMPOUNDS FOR OLEDS | OCIAD1, OCIAD2, BRD7 | KMT2A 3312/4885TDP2 1726/4885NSD2 153/4885 |
| US-20180226580-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SLCO4C1, SLCO2A1, SLCO2B1 | KMT2A 3646/4885TDP2 2480/4885NSD2 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.